Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer : a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology

• CANTORE M

収録刊行物

• J Chemother

  J Chemother 16 589-594, 2004

詳細情報

• CRID: 1571698600296777856
• NII論文ID: 10018863417
• データソース種別:
  • CiNii Articles